Clinical Trial Update: Metformin Hydrochloride as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating metformin hydrochloride as first-line therapy for locally advanced or metastatic prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• METFORMIN HYDROCHLORIDE (Metformin hydrochloride)

Snippet

Sponsor: Swiss Cancer Institute | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED